What's New
FTD in the News
In TEDx Talk, Neuroscientist Shares Her Father’s FTD Story and Her Hope for Dementia Research Breakthroughs
Leila Allen, PhD, of Florida International University (FIU), discussed the groundbreaking dementia research that she and her…
Extracellular Vesicles in Plasma Could be FTD-ALS Diagnostic Biomarker, Study Finds
A study published in Nature Medicine finds that a type of particle associated with specific cell subtypes…
Denali and Takeda Open FTD-GRN Clinical Trial Site at UPenn
Denali Therapeutics and Takeda Pharmaceutical Company’s phase 1/2 clinical trial for FTD caused by GRN mutations is…
Ohio Care Partner Shares Story to Help Others on the FTD Journey
Mary Kay Verhoff, a former FTD care partner from Ohio, recently published a book that tells the…
Can a Tau PET Tracer Aid FTD Diagnosis? Study Explores How Tracer Performs in Other Tauopathies
A study published in Science Translational Medicine explores how well the brain imaging tau PET tracer F-MK-6240…
Article Lists Ways Researchers Can Involve People with Dementia in Identifying Research Priorities
A research article published in the Journal of the American Geriatrics Society discusses how researchers can better…
AFTD Ambassador Advocates on Behalf of the Older Americans Act
AFTD Ambassador Judy Bearer advocated for the reauthorization of the Older Americans Act (OAA) in a December…
New York Software Company Awards AFTD Gift to Honor Employee’s Late Cousin
AFTD has been selected as one of three organizations to receive a gift from Mindex, a software-development…
Transposon Presents Results from Successful Phase 2 ALS/FTD Clinical Trial
Biotechnology company Transposon Therapeutics presented the results from its successful phase 2 clinical trial of its experimental…